Jpmorgan Chase & CO Cryo Cell International Inc Put Options Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CCEL
# of Institutions
21Shares Held
976KCall Options Held
0Put Options Held
0-
Hamilton Lane Advisors LLC410KShares$1.93 Million1.73% of portfolio
-
Sfi Advisors, LLC Montclair, NJ165KShares$778,5630.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA130KShares$611,4230.0% of portfolio
-
Massmutual Trust CO Fsb111KShares$522,9740.02% of portfolio
-
Geode Capital Management, LLC Boston, MA45.8KShares$215,8640.0% of portfolio
About CRYO CELL INTERNATIONAL INC
- Ticker CCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 8,519,250
- Market Cap $40.1M
- Description
- Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative med...